Literature DB >> 35002499

Vitamin D Supplementation Should Be Considered for the Treatment of COVID-19 Infection in Malaysia in View of the High Prevalence of Vitamin D Deficiency.

Shamin Mohd Saffian1.   

Abstract

Entities:  

Year:  2021        PMID: 35002499      PMCID: PMC8715881          DOI: 10.21315/mjms2021.28.6.15

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


× No keyword cloud information.
Dear Editor, The significance of vitamin D requirements for bone and muscle health is well recognised and has been repeatedly discussed in the literature. However, many readers might not be aware of the role of vitamin D in the immune system and the growing evidence that vitamin D plays a crucial role in COVID-19 infection (1, 2). This letter briefly describes observational and intervention studies on the relationship between vitamin D and COVID-19 infection and provides some insights into the local situation in Malaysia. Recently, Pereira et al. (3) conducted a systematic review of 27 observational studies that investigated the relationship between vitamin D deficiency and the severity of COVID-19 infection. The 27 studies were conducted worldwide, including Europe (n = 15), the Mediterranean (n = 2), the USA (n = 3), the Western Pacific (n = 3), South Asia (n = 2) and Indonesia (n = 2). They found that patients with severe COVID-19 had markedly low vitamin D levels and the fatality rate was high in vitamin D-deficient groups, but vitamin D deficiency was not associated with a higher risk of COVID-19 infection. It is important to note that the geographical distribution was important because COVID-19 fatalities were found to be highly correlated to latitude, which is linked to vitamin D deficiency (4). While not necessarily causative, because respiratory tract infections can lower vitamin D levels (5), these studies point towards a strong relationship between vitamin D levels and the severity of COVID-19 infection. Several randomised controlled trials (RCTs) have been conducted to investigate whether vitamin D supplementation can improve clinical outcomes in COVID-19 infections. A group of Spanish researchers treated 50 randomised patients with high doses of calcifediol plus standard care, while 26 others received only standard care. They showed that calcifediol-treated patients with COVID-19 infection required significantly less intensive care unit (ICU) treatment in hospitalised patients (6). A clinical trial conducted in India supplemented 60,000 IU of cholecalciferol in 16 COVID-19 patients, while 20 other patients received a placebo. All the patients in the trial were vitamin D deficient (defined as 25(OH)D level < 20 ng/mL). After administering the vitamin D supplementation for a week, the investigators found that it improved various COVID-19 severity markers (7). Also, two French studies (8, 9) that used a quasi-experimental study design found that vitamin D supplementation improved survival. However, not all trials have shown improvement in COVID-19-infected patients with vitamin D supplementation. A Brazilian RCT (10) published in JAMA did not demonstrate the same effect as the other trials mentioned here. However, as detailed by the editor of JAMA (11), several limitations would limit the generalisability of their findings. One may next ask, how prevalent is vitamin D deficiency in Malaysia? A local longitudinal study called MyHeARTs found that 78.9% of 1361 sampled 13-year-old Malaysian adolescents had vitamin D deficiency (12, 13). Another study of 57 pregnant women sampled from the Kuala Lumpur area found that 91% were vitamin D deficient (14). This was echoed by another larger study, where 42.4% of 535 pregnant women were found to be vitamin D deficient (15). It has also been shown that urban women in Malaysia had significantly lower vitamin D levels compared to rural women (16), while a slightly dated but still relevant study showed that approximately 68% of Malay adults in Kuala Lumpur had insufficient vitamin D levels (n = 380) (17). Overarchingly, these studies have repeatedly indicated that many Malaysians do not have the recommended level of vitamin D. It is well known that adequate exposure to sunlight together with a healthy diet is the best way to increase circulating vitamin D levels. However, because of our lifestyles in the new norm, this might not be a feasible option for everyone. Therefore, vitamin D supplementation for individuals who are deficient has been suggested by some authors as a method to increase circulating vitamin D and consequently improve innate and adaptive immunity (1). However, it should be noted that vitamin D supplementation should only be part of general measures in the fight against COVID-19. It does not, in any way, negate the need for other measures, such as a healthy diet, adequate sleep and physical exercise, avoiding and relieving stress and other proven preventative measures, including physical distancing, hand washing and wearing face masks.
  16 in total

1.  Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.

Authors:  David E Leaf; Adit A Ginde
Journal:  JAMA       Date:  2021-03-16       Impact factor: 56.272

2.  Effects of sun exposure on 25(OH) vitamin D concentration in urban and rural women in Malaysia.

Authors:  Musa Nurbazlin; Winnie Siew Swee Chee; Pendek Rokiah; Alexander Tong Boon Tan; Yee Yean Chew; Abd Rahman Siti Nusaibah; Siew Pheng Chan
Journal:  Asia Pac J Clin Nutr       Date:  2013       Impact factor: 1.662

3.  Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).

Authors:  Pankaj Malhotra; Ashu Rastogi; Anil Bhansali; Niranjan Khare; Vikas Suri; Narayana Yaddanapudi; Naresh Sachdeva; G D Puri
Journal:  Postgrad Med J       Date:  2020-11-12       Impact factor: 2.401

4.  Risk factors of vitamin D deficiency among 15-year-old adolescents participating in the Malaysian Health and Adolescents Longitudinal Research Team Study (MyHeARTs).

Authors:  Shiao Wei Quah; Hazreen Abdul Majid; Nabilla Al-Sadat; Abqariyah Yahya; Tin Tin Su; Muhammad Yazid Jalaludin
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

5.  Vitamin D and survival in COVID-19 patients: A quasi-experimental study.

Authors:  Cédric Annweiler; Bérangère Hanotte; Claire Grandin de l'Eprevier; Jean-Marc Sabatier; Ludovic Lafaie; Thomas Célarier
Journal:  J Steroid Biochem Mol Biol       Date:  2020-10-13       Impact factor: 4.292

Review 6.  Vitamin D and Its Potential Benefit for the COVID-19 Pandemic.

Authors:  Nipith Charoenngam; Arash Shirvani; Michael F Holick
Journal:  Endocr Pract       Date:  2021-03-17       Impact factor: 3.443

7.  Vitamin D deficiency in Malaysian adolescents aged 13 years: findings from the Malaysian Health and Adolescents Longitudinal Research Team study (MyHeARTs).

Authors:  Nabilla Al-Sadat; Hazreen Abdul Majid; Pei Ying Sim; Tin Tin Su; Maznah Dahlui; Mohd Fadzrel Abu Bakar; Najat Dzaki; Saidatul Norbaya; Liam Murray; Marie M Cantwell; Muhammad Yazid Jalaludin
Journal:  BMJ Open       Date:  2016-08-18       Impact factor: 2.692

8.  Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence.

Authors:  Joost Smolders; Jody van den Ouweland; Christopher Geven; Peter Pickkers; Matthijs Kox
Journal:  Metabolism       Date:  2020-11-17       Impact factor: 8.694

9.  "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".

Authors:  Marta Entrenas Castillo; Luis Manuel Entrenas Costa; José Manuel Vaquero Barrios; Juan Francisco Alcalá Díaz; José López Miranda; Roger Bouillon; José Manuel Quesada Gomez
Journal:  J Steroid Biochem Mol Biol       Date:  2020-08-29       Impact factor: 4.292

Review 10.  The role of vitamin D in reducing SARS-CoV-2 infection: An update.

Authors:  Mohammad Shah Alam; Daniel M Czajkowsky; Md Aminul Islam; Md Ataur Rahman
Journal:  Int Immunopharmacol       Date:  2021-04-17       Impact factor: 5.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.